Exelixis
EXEL
#1704
Rank
$9.65 B
Marketcap
$33.81
Share price
-0.65%
Change (1 day)
40.58%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company